Correction to: Lessons learned from phase 3 trials of immunotherapy for glioblastoma: Time for longitudinal sampling?
Neuro Oncol
.
2024 Apr 5;26(4):779.
doi: 10.1093/neuonc/noad241.
PMID:
38109270
PMCID:
PMC10995499
DOI:
10.1093/neuonc/noad241
No abstract available
Publication types
Published Erratum
Grants and funding
P01 CA163205/CA/NCI NIH HHS/United States
R01NS110942/NH/NIH HHS/United States
P01 CA163205/CA/NCI NIH HHS/United States
R01NS110942/NH/NIH HHS/United States